Advantages of heterologous expression of human D2long dopamine receptors in human neuroblastoma SH-SY5Y over human embryonic kidney 293 cells
Open Access
- 1 October 2000
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 131 (3) , 514-520
- https://doi.org/10.1038/sj.bjp.0703580
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A Novel Interaction between Adrenergic Receptors and the α-Subunit of Eukaryotic Initiation Factor 2BPublished by Elsevier ,1997
- Inhibition of N-type Ca2+ channel currents in human neuroblastoma (SH-SY5Y) cells by muscarine via stimulation of M3 receptorsNeuropharmacology, 1995
- Dopamine receptor pharmacologyTrends in Pharmacological Sciences, 1994
- Characterization of the Functional Activity of Dopamine Ligands at Human Recombinant Dopamine D4 ReceptorsJournal of Neurochemistry, 1994
- Inversion of Ca2+ current modulation during recovery of neuroblastoma cells from pertussis toxin pretreatmentFEBS Letters, 1993
- A Novel Adenylyl Cyclase Sequence Cloned from the Human Erythroleukemia Cell LineBiochemical and Biophysical Research Communications, 1993
- Measurement of GTPγS binding to specific G proteins in membranes using G‐protein antibodiesFEBS Letters, 1992
- Differential G protein-mediated coupling of D2 dopamine receptors to K+ and Ca2+ currents in rat anterior pituitary cellsNeuron, 1992
- Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neurolepticsNature, 1990
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973